NYSE · HZO

MarineMax, Inc.

$36.25 -$0.08 (-0.22%) 1D Market open
Charting by TradingView

Key Metrics

$800.28M
Market cap
—
P/E · TTM
$2.24B
Revenue · TTM
−$63.52M
Net income
EPS · TTM $-2.89
Dividend yield —
Free cash flow $169.34M
Beta · 1Y 1.83
EBITDA · TTM −$25.92M
Gross margin 32.7%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 23
    A material event was filed (Form 8-K).

    8-K - MARINEMAX INC (0001057060) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Feb 25
    The stock moved +8.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 25
  • Feb 2
    The stock moved +11.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 2

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$800.28M
Enterprise value$985.47M
Shares outstanding22.0M
52-wk range$21.41 – $38.14
Avg volume · 20D366.3K
Net cash −$185.19M
Book value / share$42.40
IndustryRetail-Auto & Home Supply Stores
ExchangeNYSE
About MarineMax, Inc.
IPO dateJun 3, 1998
Employees3385

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E—
P/S0.36
P/FCF4.73
EV/EBITDA—
EV/Sales0.44
Graham №—

Profitability

Gross 32.7%
Operating -3.4%
Net -2.8%
FCF 7.6%
ROE / ROIC -6.8% · -5.6%

Financial Health

Current ratio1.18
Quick ratio0.32
Debt / equity0.40
Debt / EBITDA -14.44
Net cash −$185.19M
Working capital$177.66M

Cash Flow · TTM

Operating CF $218.74M
Capex −$49.40M
Free cash flow $169.34M
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

1.6
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

—
Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings